Your browser does not support iframes.
N&O 100
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
TRANSITION
(TSX:
TTH
)
3.060
CAD
+0.060 (+2.00%)
Streaming Delayed Price
/ Updated:
10:20 AM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
2,700
Open
3.000
Bid (Size)
3.000 (0)
Ask (Size)
3.080 (0)
Prev. Close
3.000
Today's Range
3.000 - 3.060
52wk Range
1.740 - 3.720
Shares Outstanding
26,921,302
Dividend Yield
N/A
Top News
More News
Transition Therapeutics Announces Third Quarter Fiscal 2013 Financial Results
May 07, 2013
from
PR Newswire
Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. EST
May 06, 2013
from
PR Newswire
More News
Read More
Free Research Reports on DDD, ESRX, NBS and TTHI Issued by the Bedford Report
May 01, 2013
from
Marketwired News Releases
PennyStocks.com Announces Trade Alerts on: ONCS, WSGP, DCTH, and TTHI
May 01, 2013
from
Marketwired News Releases
Markets Advance As Consumer Confidence Rises
April 30, 2013
category
Market News
from
MarketMinute.com Market Updates
Unusual 11 Mid-Day Movers 04/30: (TTHI) (DRRX) (PTIE) Higher; (DCTH) (NBS) (NUAN) Lower
April 30, 2013
from
StreetInsider.com News Articles
Transition Therapeutics (TTHI) leaps on study results
April 30, 2013
from
BAYSTREET RSS FEED
Transition Therapeutics Shares Sharply Higher as Data from TT-401 in Type 2 Diabetes Better Than Expected
April 30, 2013
category
Benzinga
,
News
,
FDA
, and 1 more.
from
Latest Articles from Benzinga.com
Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401
April 30, 2013
from
PR Newswire
Bullish Two Hundred Day Moving Average Cross - TTH.CA
April 23, 2013
category
Dividends
from
Dividend Channel
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.